BioTheryX
PrivateLast Round
Corporate Funding
Apr 5, 2023
Total Funding Raised
$127M
Company Overview
BioTheryx is a biopharmaceutical company focused on developing innovative treatments for life-threatening diseases through targeted protein degradation and molecular glues that enhance the body's ability to eliminate harmful proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioTheryX Comps
Public and private peers based on sector, stage, and business model.
BioTheryX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 5, 2023 | ||||
| Series E | May 20, 2021 | ||||
| Series D | Jul 28, 2020 | ||||
| VC Round | Nov 30, 2010 |
Key People
Founding team and executive leadership
BioTheryX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series E |
| Wedbush Healthcare Partners | Series E |
| Farallon Capital Management | Series E |
| Deep Track Capital | Series E |
| Avidity Partners | Series E |
| Irving Investors | Series E |
| Wedbush | Series E |
BioTheryX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioTheryX's valuation, stock price, and market status.
